Article Details
Retrieved on: 2025-04-10 21:20:45
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Lexeo Therapeutics' gene therapies for Friedreich's ataxia and Alzheimer's. While focusing on LX2006 for FA cardiomyopathy, it briefly mentions LX1001 for Alzheimer's, integrating Alzheimer's into the broader context of genetic therapies.
Article found on: www.cgtlive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here